Bliss GVS Pharma submits disclosure of related party transactions

02 Dec 2019 Evaluate

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bliss GVS Pharma has informed about submission of disclosure of related party transactions on the basis on consolidated financial statements for the half year ended September 30, 2019. 

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

210.30 -14.70 (-6.53%)
24-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1730.55
Dr. Reddys Lab 1299.40
Cipla 1326.30
Zydus Lifesciences 904.35
Lupin 2251.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×